The FDA approved an application from Amneal Pharmaceuticals to make dexmedetomidine hydrochloride 0.9 percent sodium chloride injection, which is used to sedate ventilated patients and non-intubated patients during surgery.
The agency also approved an application from Accord Healthcare to make succinylcholine chloride injection, which is used for general anesthesia and to provide muscle relaxation during surgery or ventilation.
Demand for drugs needed to put patients on ventilators has spiked during the pandemic.
“The FDA recognizes the increased demand for certain products during the COVID-19 public health emergency, and we remain deeply committed to facilitating access to medical products to help address critical needs of the American public,” the agency said.
More articles on pharmacy:
AstraZeneca gets $1B from US to produce COVID-19 vaccine
Generic drugmaker Akorn files for bankruptcy
7 things to know about startup drugmaker Phlow
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.